BACKGROUND AND OBJECTIVES: Critically ill patients with AKI necessitating renal replacement therapy (RRT) have high in-hospital mortality, and survivors are at risk for kidney dysfunction at hospital discharge. The objective was to evaluate the association between impaired kidney function at hospital discharge with long-term renal and overall survival. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Degree of kidney dysfunction in relation to long-term effects on renal survival and patient mortality was investigated in a retrospective cohort study of 1220 adults admitted to an intensive care unit who received continuous RRT between 1994 and 2010. RESULTS: After hospital discharge, median follow-up of survivors (n=475) was 8.5 years (range, 1-17 years); overall mortality rate was 75%. Only 170 (35%) patients were discharged with an estimated GFR (eGFR) >60 ml/min per 1.73 m(2). Multivariate proportional hazards regression analysis demonstrated that age, nonsurgical type of admission, preexisting kidney disease, malignancy, and eGFR of 29-15 ml/min per 1.73 m(2) (hazard ratio [HR], 1.62; 95% confidence interval [CI], 1.01 to 2.58) and eGFR <15 ml/min per 1.73 m(2) (HR, 1.93; 95% CI, 1.23 to 3.02) at discharge were independent predictors of increased mortality. Renal survival was significantly associated with degree of kidney dysfunction at discharge. An eGFR of 29-15 ml/min per 1.73 m(2) (HR, 26.26; 95% CI, 5.59 to 123.40) and <15 ml/min per 1.73 m(2) (HR, 172.28; 95% CI, 37.72 to 786.75) were independent risk factors for initiation of long-term RRT. CONCLUSIONS: Most critically ill patients surviving AKI necessitating RRT have impaired kidney function at hospital discharge. An eGFR <30 ml/min per 1.73 m(2) is a strong risk factor for decreased long-term survival and poor renal survival.
BACKGROUND AND OBJECTIVES:Critically illpatients with AKI necessitating renal replacement therapy (RRT) have high in-hospital mortality, and survivors are at risk for kidney dysfunction at hospital discharge. The objective was to evaluate the association between impaired kidney function at hospital discharge with long-term renal and overall survival. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Degree of kidney dysfunction in relation to long-term effects on renal survival and patient mortality was investigated in a retrospective cohort study of 1220 adults admitted to an intensive care unit who received continuous RRT between 1994 and 2010. RESULTS: After hospital discharge, median follow-up of survivors (n=475) was 8.5 years (range, 1-17 years); overall mortality rate was 75%. Only 170 (35%) patients were discharged with an estimated GFR (eGFR) >60 ml/min per 1.73 m(2). Multivariate proportional hazards regression analysis demonstrated that age, nonsurgical type of admission, preexisting kidney disease, malignancy, and eGFR of 29-15 ml/min per 1.73 m(2) (hazard ratio [HR], 1.62; 95% confidence interval [CI], 1.01 to 2.58) and eGFR <15 ml/min per 1.73 m(2) (HR, 1.93; 95% CI, 1.23 to 3.02) at discharge were independent predictors of increased mortality. Renal survival was significantly associated with degree of kidney dysfunction at discharge. An eGFR of 29-15 ml/min per 1.73 m(2) (HR, 26.26; 95% CI, 5.59 to 123.40) and <15 ml/min per 1.73 m(2) (HR, 172.28; 95% CI, 37.72 to 786.75) were independent risk factors for initiation of long-term RRT. CONCLUSIONS: Most critically illpatients surviving AKI necessitating RRT have impaired kidney function at hospital discharge. An eGFR <30 ml/min per 1.73 m(2) is a strong risk factor for decreased long-term survival and poor renal survival.
Authors: Ilknur Bahar; Ahmet Akgul; Mehmet Ali Ozatik; Kerem M Vural; Ali E Demirbag; Mediha Boran; Oguz Tasdemir Journal: Perfusion Date: 2005-10 Impact factor: 1.972
Authors: K Akposso; A Hertig; R Couprie; A Flahaut; C Alberti; G A Karras; J P Haymann; M A Costa De Beauregard; A Lahlou; E Rondeau; J D Sraer Journal: Intensive Care Med Date: 2000-04 Impact factor: 17.440
Authors: Annika Ahlström; Minna Tallgren; Seija Peltonen; Pirjo Räsänen; Ville Pettilä Journal: Intensive Care Med Date: 2005-07-28 Impact factor: 17.440
Authors: Ion D Bucaloiu; H Lester Kirchner; Evan R Norfolk; James E Hartle; Robert M Perkins Journal: Kidney Int Date: 2011-12-07 Impact factor: 10.612
Authors: F Liaño; C Felipe; M T Tenorio; M Rivera; V Abraira; J M Sáez-de-Urturi; J Ocaña; C Fuentes; S Severiano Journal: Kidney Int Date: 2007-01-31 Impact factor: 10.612
Authors: Berthus G Loef; Anne H Epema; Ton D Smilde; Robert H Henning; Tjark Ebels; Gerjan Navis; Coen A Stegeman Journal: J Am Soc Nephrol Date: 2004-11-24 Impact factor: 10.121
Authors: Sean M Bagshaw; Kevin B Laupland; Christopher J Doig; Garth Mortis; Gordon H Fick; Melissa Mucenski; Tomas Godinez-Luna; Lawrence W Svenson; Tom Rosenal Journal: Crit Care Date: 2005-10-25 Impact factor: 9.097
Authors: Eric A J Hoste; Gilles Clermont; Alexander Kersten; Ramesh Venkataraman; Derek C Angus; Dirk De Bacquer; John A Kellum Journal: Crit Care Date: 2006-05-12 Impact factor: 9.097
Authors: Susanne Stads; K Merijn Kant; Margriet F C de Jong; Wouter de Ruijter; Christa M Cobbaert; Michiel G H Betjes; Diederik Gommers; Heleen M Oudemans-van Straaten Journal: Blood Purif Date: 2019-07-22 Impact factor: 2.614
Authors: Jeanne Frisby-Zedan; Matthew F Barhight; Mahima Keswani; Jennifer Arzu; Delphine Nelson Journal: Pediatr Nephrol Date: 2022-05-13 Impact factor: 3.714
Authors: V Schwenger; D Kindgen-Milles; C Willam; A Jörres; W Druml; D Czock; S J Klein; M Oppert; M Schmitz; J T Kielstein; A Zarbock; M Joannidis; S John Journal: Med Klin Intensivmed Notfmed Date: 2018-03-15 Impact factor: 0.840
Authors: Jonathan A Bolanos; Christina M Yuan; Dustin J Little; David K Oliver; Steven R Howard; Kevin C Abbott; Stephen W Olson Journal: Clin J Am Soc Nephrol Date: 2015-09-03 Impact factor: 8.237
Authors: Chandan Vangala; Maulin Shah; Natasha N Dave; Layth Al Attar; Sankar D Navaneethan; Venkat Ramanathan; Susan Crowley; Wolfgang C Winkelmayer Journal: Ren Fail Date: 2021-12 Impact factor: 2.606